BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37452092)

  • 1. A novel NFAT1-IL6/JAK/STAT3 signaling pathway related nomogram predicts overall survival in gliomas.
    Zhang C; Wang Y; Shao W; Zhou D; Yu D; Hou S; Lin N
    Sci Rep; 2023 Jul; 13(1):11401. PubMed ID: 37452092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MCM10 as a novel prognostic biomarker and its relevance to immune infiltration in gliomas.
    Tian QS; Zhang Q; Huang W
    Technol Health Care; 2023; 31(4):1301-1317. PubMed ID: 36872806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NFAT1-regulated IL6 signalling contributes to aggressive phenotypes of glioma.
    Jiang Y; Han S; Cheng W; Wang Z; Wu A
    Cell Commun Signal; 2017 Dec; 15(1):54. PubMed ID: 29258522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Risk Score Signature Consisting of Six Immune Genes Predicts Overall Survival in Patients with Lower-Grade Gliomas.
    Wu Y; Peng Z; Gu S; Wang H; Xiang W
    Comput Math Methods Med; 2022; 2022():2558548. PubMed ID: 35186111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The evaluation of six genes combined value in glioma diagnosis and prognosis.
    Lin P; He L; Tian N; Qi X
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):12413-12433. PubMed ID: 37439825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development and Evaluation of Prognostic Nomogram Model for Adult Ventricle Glioma Patients].
    Zhang HD; Niu XD; Zhou XW; Yang Y; Li JM; Gan YJ; Wang X; Liu YH; Mao Q
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Jul; 53(4):588-596. PubMed ID: 35871728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioinformatics Analysis of Expression Profiles and Prognostic Values of the Signal Transducer and Activator of Transcription Family Genes in Glioma.
    Ji W; Liu Y; Xu B; Mei J; Cheng C; Xiao Y; Yang K; Huang W; Jiao J; Liu H; Shao J
    Front Genet; 2021; 12():625234. PubMed ID: 34276757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel DNA repair-related nomogram predicts survival in low-grade gliomas.
    Li G; Wu F; Zeng F; Zhai Y; Feng Y; Chang Y; Wang D; Jiang T; Zhang W
    CNS Neurosci Ther; 2021 Feb; 27(2):186-195. PubMed ID: 33063446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ferroptosis-related gene signature correlates with the tumor immune features and predicts the prognosis of glioma patients.
    Hu Y; Tu Z; Lei K; Huang K; Zhu X
    Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34726238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas.
    Zhang H; Li X; Li Y; Chen B; Zong Z; Shen L
    Front Immunol; 2020; 11():603341. PubMed ID: 33363544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selenoprotein GPX1 is a prognostic and chemotherapy-related biomarker for brain lower grade glioma.
    Chen X; Fu G; Li L; Zhao Q; Ke Z; Zhang R
    J Trace Elem Med Biol; 2022 Dec; 74():127082. PubMed ID: 36155420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.
    Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z
    BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of clinical significance and prospective molecular mechanism of main elements of the JAK/STAT pathway in hepatocellular carcinoma.
    Wang X; Liao X; Yu T; Gong Y; Zhang L; Huang J; Yang C; Han C; Yu L; Zhu G; Qin W; Liu Z; Zhou X; Liu J; Han Q; Peng T
    Int J Oncol; 2019 Oct; 55(4):805-822. PubMed ID: 31485610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N6-methyladenine-related genes affect biological behavior and the prognosis of glioma.
    Qu S; Chen Z; Liu B; Liu J; Wang H
    Cancer Med; 2021 Jan; 10(1):98-108. PubMed ID: 33264518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel model based on necroptosis-related genes for predicting immune status and prognosis in glioma.
    Yuan YS; Jin X; Chen L; Liao JM; Zhang Y; Yu KW; Li WK; Cao SW; Huang XZ; Kang CM
    Front Immunol; 2022; 13():1027794. PubMed ID: 36389690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An autophagic gene-based signature to predict the survival of patients with low-grade gliomas.
    Chen J; Li Y; Han X; Pan Y; Qian X
    Cancer Med; 2021 Mar; 10(5):1848-1859. PubMed ID: 33591634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid metabolism-related gene signature predicts prognosis and depicts tumor microenvironment immune landscape in gliomas.
    Li J; Zhang S; Chen S; Yuan Y; Zuo M; Li T; Wang Z; Liu Y
    Front Immunol; 2023; 14():1021678. PubMed ID: 36860853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Signature Constructed by RNA-Binding Protein Coding Genes to Improve Overall Survival Prediction of Glioma Patients.
    Tu Z; Shu L; Li J; Wu L; Tao C; Ye M; Zhu X; Huang K
    Front Cell Dev Biol; 2020; 8():588368. PubMed ID: 33634092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of a Prognostic Gene Signature Associated with Immune Infiltration in Glioma: A Comprehensive Analysis Based on the CGGA.
    Gong X; Liu L; Xiong J; Li X; Xu J; Xiao Y; Li J; Luo X; Mao D; Liu L
    J Oncol; 2021; 2021():6620159. PubMed ID: 33790966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and validation of an individualized prognostic signature of lower-grade glioma based on nine immune related long non-coding RNA.
    Maimaiti A; Jiang L; Wang X; Shi X; Pei Y; Hao Y; Paerhati H; Zibibula Y; Abudujielili A; Kasimu M
    Clin Neurol Neurosurg; 2021 Feb; 201():106464. PubMed ID: 33454543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.